BioNTech's Chinese partner Shanghai Fosun Pharmaceutical Group plans to import 7.2 million doses of the German company's COVID-19 vaccine in the first half of 2021, Caixin learned from several people familiar with the company's plan.
Fosun is arranging logistics with several airlines to start transporting the vaccine from BioNTech's German factory to China starting in January. Based on available data, the company can import 1.2 million doses a month, the people said.